ASSESSING THE DRUG SUPPLY AND DISTRIBUTION PROCESS OF MDA-LF PROGRAM OF LYMPHATIC FILARIASIS; POST 7 YEARS OF THE PROGRAM IMPLEMENTATION IN PEKALONGAN TOWN CENTRAL JAVA, INDONESIA.
- Faculty of Public Health, University of Diponegoro, Tembalang, Indonesia.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
MDA-LF is part of a global programme to eliminate lymphatic filariasis by less than 1% amongst the population, launched by World Health Organization (WHO) in 2000. This study aimed to find out the magnitude of coverage, the operational issues related to the process of drug distribution and as well as the success factors of MDA-LF LF. Methods: This study used mixed method, interviewed 26 respondents and collected secondary data from Pekalongan Town Health Office. Results: The coverage rate of MDA-LF LF in Pekalongan Town was 93% but the LF rate was still stand at >1%. There was no hindrance with the MDA-LF distribution, however, many people did not want to consume the MDA-LF drug package.
- ErdiansyahAdhami, Devisda Shay A, Bagas W.U., Febri Z F, Totalenesya R S, Wilsa Patricia, Nita Alanti, YunitaDewiAnggraeni, WinaspitaAuliaPutri, Ra Bintang P, MadhaQoyuledyT, PrismaDiandari, YudhaNurdian. A Neglected Tropical Disease: Filariasis Caused by BrugiaMalayi Infections. 2018
- Fact Sheet about Filariasis [Internet]. 2017. Available from: http://www.who.int/mediacentre/factsheets/fs102/en/
- IndraWijaya, winfreypangestu. Giant Scrotal Hydrocele and Bilateral Leg Lymphedema as clinical Manifestation of Chronic Lymphatic Filariasis. The indonesian journal of internal medicine. 2016;48:239-241
- S. Department of Health and Human Services. Centers for Disease Control and Prevention. Office of the Director, Office of Strategy and Innovation. Introduction to program evaluation for public health programs: A self-study guide. Atlanta, GA: Centers for Disease Control and Prevention, 2011.
- Paul E Simonsen, Stephen M Magesa, Yahya A Derua, Erling M Pedersen. Lymphatic filariasis control in TangaRegion,Tanzania: status after eight rounds of mass drugadministration. Parasites & vectors. 2014; (7).
- TaniawatiSupali. Summary of the current situation of filariasis in Indonesia. 2015; (3).
- Supali, Ismid, R?ckert, Fischer P. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae. Trop Med Int Heal. 2002;7(10):894?901.
- Budyanti. current status of Lymphatic filariasis in pekalongan. 2018; (5).
- Roy RN, Sarkar AP, Misra R, Chakroborty A, Mondal TK BK. Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India. 2013;31:171?177.
- V. Babu S kar. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Trop Med Int Heal. 2005;
- Mirani V, Channa T Yahathugoda, Darshana Wickramasinghe, Kithsiri N Gunawardena, Rohan A Dharmadasa, Kanchana K Vidanapathirana SHW and WAS. Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA-LF) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka. Filaria J. 2007;6.
- Goldman AS, Guisinger VH, Aikins M, Amarillo MLE, Belizario VY, Garshong B et al. National Mass Drug Administration Costs for Lymphatic Filariasis Elimination. PLos Negl Trop Dis. 2007;1(1).
- Agrawal S. Lymphatic Filariasis in India : Problems, Challenges and New Initiatives. ScienceDirect. 2006;62(4):359?62.
[Ali Jarghon, Hanifa Denny and Chriswardani Suryawati. (2019); ASSESSING THE DRUG SUPPLY AND DISTRIBUTION PROCESS OF MDA-LF PROGRAM OF LYMPHATIC FILARIASIS; POST 7 YEARS OF THE PROGRAM IMPLEMENTATION IN PEKALONGAN TOWN CENTRAL JAVA, INDONESIA. Int. J. of Adv. Res. 7 (Mar). 1422-1427] (ISSN 2320-5407). www.journalijar.com
Diponegoro university
